The various states of von Willebrand factor and their function in physiology and pathophysiology

The specific interactions of von Willebrand factor (VWF) with the vessel wall, platelets or other interfaces strongly depend on (a shear-induced) VWF activation. Shear flow has been shown to induce a conformational transition of VWF, but is modulated by its thermodynamic state (state-function relationship). The state in turn is determined by physical (e.g. vessel geometry), physico-chemical (e.g. pH) and molecular-biological (e.g. mutants, binding) factors. Combining established results with recent insights, we reconstruct VWF biology and its state-function relationship from endothelial cell release to final degradation in the human vasculature. After VWF secretion, endothelial-anchored and shear activated VWF multimers can rapidly interact with surrounding colloids, typically with platelets. Simultaneously, this VWF activation enables ADAMTS13 to cleave VWF multimers thereby limiting VWF binding capacity. The subsequent cell-surface dissociation leads to a VWF recoiling to a globular conformation, shielding from further degradation by ADAMTS13. High local concentrations of these soluble VWF multimers, transported to the downstream vasculature, are capable for an immediate reactivation and re-polymerisation initiating colloid-binding or VWF-colloid aggregation at the site of inflamed endothelium, vessel injuries or pathological high-shear areas. Focusing on these functional steps in the lifecycle of VWF, its qualitative and quantitative deficiencies in the different VWD types will facilitate more precise diagnostics and reliable risk stratification for prophylactic therapies. The underlying biophysical principles are of general character, which broadens prospective studies on the physiological and pathophysiological impact of VWF and VWF-associated diseases and beares hope for a more universal understanding of an entire class of phenomena.

[1]  A Alexander-Katz,et al.  Shear-induced unfolding triggers adhesion of von Willebrand factor fibers , 2007, Proceedings of the National Academy of Sciences.

[2]  R S Reneman,et al.  Wall shear rate in arterioles in vivo: least estimates from platelet velocity profiles. , 1988, The American journal of physiology.

[3]  A. Wixforth,et al.  Acoustic driven flow and lattice Boltzmann simulations to study cell adhesion in biofunctionalized mu-fluidic channels with complex geometry. , 2010, Biomicrofluidics.

[4]  K. Ghosh,et al.  An atypical manifestation of acquired von Willebrand syndrome (AVWS) associated with systemic lupus erythematosus (SLE) , 2013, Annals of Hematology.

[5]  Z. Ruggeri Structure of von Willebrand factor and its function in platelet adhesion and thrombus formation. , 2001, Best practice & research. Clinical haematology.

[6]  C. Denis,et al.  Role of von Willebrand factor in tumor metastasis. , 2007, Thrombosis research.

[7]  J. Oldenburg,et al.  Recombinant expression of mutations causing von Willebrand disease type Normandy: characterization of a combined defect of factor VIII binding and multimerization , 2004, Thrombosis and Haemostasis.

[8]  Eric W. Frey,et al.  Mechanical activation of a multimeric adhesive protein through domain conformational change. , 2013, Physical review letters.

[9]  A. Reininger Platelet function under high shear conditions , 2009, Hämostaseologie.

[10]  Brian Savage,et al.  Initiation of Platelet Adhesion by Arrest onto Fibrinogen or Translocation on von Willebrand Factor , 1996, Cell.

[11]  A. Bernardo,et al.  Hemostasis, Thrombosis, and Vascular Biology , 2022 .

[12]  D. Metcalf,et al.  Formation and function of Weibel-Palade bodies , 2008, Journal of Cell Science.

[13]  A. Alexander-Katz,et al.  Von Willlebrand adhesion to surfaces at high shear rates is controlled by long-lived bonds. , 2013, Biophysical journal.

[14]  T. Springer,et al.  Biology and physics of von Willebrand factor concatamers , 2011, Journal of thrombosis and haemostasis : JTH.

[15]  A. Zarbock,et al.  von Willebrand factor promotes leukocyte extravasation. , 2010, Blood.

[16]  P. Rosenthal,et al.  Structural organization of Weibel-Palade bodies revealed by cryo-EM of vitrified endothelial cells , 2009, Proceedings of the National Academy of Sciences.

[17]  S. W. Schneider,et al.  The mechanism of melanoma-associated thrombin activity and von Willebrand factor release from endothelial cells. , 2010, The Journal of investigative dermatology.

[18]  M. Woodward,et al.  Evidence that high von Willebrand factor and low ADAMTS-13 levels independently increase the risk of a non-fatal heart attack , 2008, Journal of thrombosis and haemostasis : JTH.

[19]  Alfredo Alexander-Katz,et al.  Elongational flow induces the unfolding of von Willebrand factor at physiological flow rates. , 2010, Biophysical journal.

[20]  J. Moake,et al.  P-selectin anchors newly released ultralarge von Willebrand factor multimers to the endothelial cell surface. , 2004, Blood.

[21]  Arnan Mitchell,et al.  A shear gradient–dependent platelet aggregation mechanism drives thrombus formation , 2009, Nature Medicine.

[22]  G. Truskey,et al.  Transport phenomena in biological systems , 2004 .

[23]  O. Christophe,et al.  Clearance of von Willebrand factor , 2008, Thrombosis and Haemostasis.

[24]  C. Ruan,et al.  Shear-induced interaction of platelets with von Willebrand factor results in glycoprotein Ibalpha shedding. , 2009, American journal of physiology. Heart and circulatory physiology.

[25]  F. Cohen,et al.  Biochemistry and genetics of von Willebrand factor. , 1998, Annual review of biochemistry.

[26]  A. Weyrich,et al.  The evolving role of platelets in inflammation , 2003, Journal of thrombosis and haemostasis : JTH.

[27]  Scott L. Diamond,et al.  Selectin-Like Kinetics and Biomechanics Promote Rapid Platelet Adhesion in Flow: The GPIbα-vWF Tether Bond , 2002 .

[28]  A. Chauhan,et al.  Formation of platelet strings and microthrombi in the presence of ADAMTS‐13 inhibitor does not require P‐selectin or β3 integrin , 2007, Journal of thrombosis and haemostasis : JTH.

[29]  L. Ju,et al.  The N-terminal Flanking Region of the A1 Domain Regulates the Force-dependent Binding of von Willebrand Factor to Platelet Glycoprotein Ibα* , 2013, The Journal of Biological Chemistry.

[30]  D W Crawford,et al.  Analysis of pulsatile, viscous blood flow through diseased coronary arteries of man. , 1977, Journal of biomechanics.

[31]  C. Gahmberg,et al.  P-selectin glycoprotein ligand 1 and beta2-integrins cooperate in the adhesion of leukocytes to von Willebrand factor. , 2006, Blood.

[32]  Albert van den Berg,et al.  Atherosclerotic geometries exacerbate pathological thrombus formation poststenosis in a von Willebrand factor-dependent manner , 2013, Proceedings of the National Academy of Sciences.

[33]  Qiong Wang,et al.  The unfolded von Willebrand factor response in bloodstream: the self-association perspective , 2012, Journal of Hematology & Oncology.

[34]  S. Diamond,et al.  Selectin-like kinetics and biomechanics promote rapid platelet adhesion in flow: the GPIb/spl alpha/-vWF tether bond , 2002, Proceedings of the Second Joint 24th Annual Conference and the Annual Fall Meeting of the Biomedical Engineering Society] [Engineering in Medicine and Biology.

[35]  A. Chauhan,et al.  Abbreviations used: AD- , 2022 .

[36]  S. Susen,et al.  Acquired von Willebrand syndrome in aortic stenosis. , 2003, The New England journal of medicine.

[37]  T. Foroud,et al.  Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura , 2001, Nature.

[38]  Scott L. Diamond,et al.  Direct Observation of von Willebrand Factor Elongation and Fiber Formation on Collagen During Acute Whole Blood Exposure to Pathological Flow , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[39]  P. Mannucci,et al.  von Willebrand factor: a marker of endothelial damage? , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[40]  V. Babich,et al.  Selective release of molecules from Weibel-Palade bodies during a lingering kiss. , 2008, Blood.

[41]  H. Tsai Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion. , 1996, Blood.

[42]  M. Steinhoff,et al.  Microfluidic reveals generation of platelet-strings on tumoractivated endothelium , 2007, Thrombosis and Haemostasis.

[43]  D. Ogden,et al.  Rate, extent and concentration dependence of histamine‐evoked Weibel–Palade body exocytosis determined from individual fusion events in human endothelial cells , 2007, The Journal of physiology.

[44]  T. Walz,et al.  Sequence and structure relationships within von Willebrand factor. , 2012, Blood.

[45]  M. Laffan,et al.  N-linked glycosylation of VWF modulates its interaction with ADAMTS13. , 2008, Blood.

[46]  D. Wagner,et al.  The vessel wall and its interactions. , 2008, Blood.

[47]  Z. Ruggeri,et al.  New perspectives on von Willebrand factor functions in hemostasis and thrombosis. , 2005, Seminars in hematology.

[48]  Sriram Neelamegham,et al.  Solution Structure of Human von Willebrand Factor Studied Using Small Angle Neutron Scattering* , 2006, Journal of Biological Chemistry.

[49]  H. Oberleithner,et al.  Secretion Pores in Human Endothelial Cells during Acute Hypoxia , 2002, The Journal of Membrane Biology.

[50]  Volker Huck,et al.  Blood-clotting-inspired reversible polymer–colloid composite assembly in flow , 2013, Nature Communications.

[51]  V. Babich,et al.  Differential Effect of Extracellular Acidosis on the Release and Dispersal of Soluble and Membrane Proteins Secreted from the Weibel-Palade Body , 2009, Journal of Biological Chemistry.

[52]  Jongseong Kim,et al.  A mechanically stabilized receptor–ligand flex-bond important in the vasculature , 2010, Nature.

[53]  Robyn Roth,et al.  Integrin alpha(v)beta(3) on human endothelial cells binds von Willebrand factor strings under fluid shear stress. , 2009, Blood.

[54]  Matthias F. Schneider,et al.  Soluble plasma-derived von Willebrand factor assembles to a haemostatically active filamentous network , 2007, Thrombosis and Haemostasis.

[55]  D. Baruch,et al.  von Willebrand factor and platelet function. , 1989, Bailliere's clinical haematology.

[56]  A Alexander-Katz,et al.  Shear-flow-induced unfolding of polymeric globules. , 2006, Physical review letters.

[57]  J. Ware,et al.  Distinct antithrombotic consequences of platelet glycoprotein Ibα and VI deficiency in a mouse model of arterial thrombosis , 2006, Journal of thrombosis and haemostasis : JTH.

[58]  R. Schneppenheim,et al.  von Willebrand factor: the complex molecular genetics of a multidomain and multifunctional protein , 2011, Journal of thrombosis and haemostasis : JTH.

[59]  Carsten Werner,et al.  A practical guide to quantify cell adhesion using single-cell force spectroscopy. , 2013, Methods.

[60]  T. Luger,et al.  Tumor-derived matrix metalloproteinase-1 targets endothelial proteinase-activated receptor 1 promoting endothelial cell activation. , 2006, Cancer research.

[61]  C. Blomstrand,et al.  Plasma levels of von Willebrand factor in the etiologic subtypes of ischemic stroke , 2011, Journal of thrombosis and haemostasis : JTH.

[62]  M. Furlan,et al.  Von Willebrand factor: molecular size and functional activity , 1996, Annals of Hematology.

[63]  Junmei Chen,et al.  Oxidative modification of von Willebrand factor by neutrophil oxidants inhibits its cleavage by ADAMTS13. , 2010, Blood.

[64]  R. Montgomery,et al.  von Willebrand factor storage and multimerization: 2 independent intracellular processes. , 2000, Blood.

[65]  O. Christophe,et al.  On the Versatility of von Willebrand Factor , 2013, Mediterranean journal of hematology and infectious diseases.

[66]  C. Denis,et al.  Blocking von Willebrand factor for treatment of cutaneous inflammation. , 2014, Journal of Investigative Dermatology.

[67]  A. Chauhan,et al.  HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY von Willebrand factor and factor VIII are independently required to form stable occlusive thrombi in injured veins , 2007 .

[68]  Thomas N. Sato,et al.  Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen. , 2000, The Journal of clinical investigation.

[69]  Sriram Neelamegham,et al.  Fluid shear induces conformation change in human blood protein von Willebrand factor in solution. , 2009, Biophysical journal.

[70]  B. Lämmle,et al.  von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models. , 2011, Blood.

[71]  D. Deykin,et al.  Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. , 1982, The New England journal of medicine.

[72]  T. Wieland,et al.  Highly invasive melanoma cells activate the vascular endothelium via an MMP-2/integrin αvβ5-induced secretion of VEGF-A. , 2012, The American journal of pathology.

[73]  J. Moake von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura. , 2004, Seminars in hematology.

[74]  C. Weidenmaier,et al.  Ultralarge von Willebrand Factor Fibers Mediate Luminal Staphylococcus aureus Adhesion to an Intact Endothelial Cell Layer Under Shear Stress , 2013, Circulation.

[75]  H. Gralnick,et al.  von Willebrand factor binds specifically to sulfated glycolipids. , 1986, The Journal of biological chemistry.

[76]  Z. Ruggeri,et al.  The role of von Willebrand factor in thrombus formation. , 2007, Thrombosis research.

[77]  A. Reininger VWF attributes--impact on thrombus formation. , 2008, Thrombosis research.

[78]  A. Federici,et al.  Activation-independent platelet adhesion and aggregation under elevated shear stress. , 2005, Blood.

[79]  A. Wixforth,et al.  Circulating but not immobilized N-deglycosylated von Willebrand factor increases platelet adhesion under flow conditions. , 2013, Biomicrofluidics.

[80]  A. Ganser,et al.  Diagnostic workup of patients with acquired von Willebrand syndrome: a retrospective single‐centre cohort study , 2008, Journal of thrombosis and haemostasis : JTH.

[81]  Matthias F. Schneider,et al.  Delay of acute intracellular pH recovery after acidosis decreases endothelial cell activation , 2007, Journal of cellular physiology.

[82]  Jizhong Lou,et al.  Platelet glycoprotein Ibalpha forms catch bonds with human WT vWF but not with type 2B von Willebrand disease vWF. , 2008, The Journal of clinical investigation.

[83]  Brian Savage,et al.  Specific Synergy of Multiple Substrate–Receptor Interactions in Platelet Thrombus Formation under Flow , 1998, Cell.

[84]  Z. Ruggeri Von Willebrand factor: Looking back and looking forward , 2007, Thrombosis and Haemostasis.

[85]  R. Hynes,et al.  A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[86]  D. Wagner Cell biology of von Willebrand factor. , 1990, Annual review of cell biology.

[87]  H. Oberleithner,et al.  Molecular weights of individual proteins correlate with molecular volumes measured by atomic force microscopy , 1998, Pflügers Archiv.

[88]  Michael Leitner,et al.  Increased imaging speed and force sensitivity for bio-applications with small cantilevers using a conventional AFM setup , 2012, Micron.

[89]  F. Zaccardi,et al.  The Oxidative Modification of Von Willebrand Factor Is Associated with Thrombotic Angiopathies in Diabetes Mellitus , 2013, PloS one.

[90]  Kazuo Fujikawa,et al.  ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions. , 2002, Blood.

[91]  L. Hoyer,et al.  von Willebrand factor and platelet function. , 1986, Annual review of medicine.

[92]  A. Reininger Function of von Willebrand factor in haemostasis and thrombosis , 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

[93]  Steven Finkbeiner,et al.  Mechanoenzymatic Cleavage of the Ultralarge Vascular Protein von Willebrand Factor , 2009 .